The company sold 75,000 shares to one accredited investor at $20.19 per share, accumulating gross proceeds of approximately $1.5 million. Additionally, Zivo Bioscience granted 38,478 shares as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback